Analysis of Choline and its Metabolites on the Finnigan LTQ

Similar documents
for the Identification of Phosphorylated Peptides

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

Characterization of an Unknown Compound Using the LTQ Orbitrap

Title: Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after. single oral administration to healthy Japanese volunteers

Sample Concentration and Analysis of Human Hormones in Drinking Water

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

LC-MS/MS Method for the Determination of Tenofovir from Plasma

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Increased Identification Coverage and Throughput for Complex Lipidomes

Determination of B-vitamins in Energy Drinks by CE/MS/MS

Rapid and Sensitive Screening of Benzodiazepines in Serum Using Liquid Chromatography-APCI-Linear Ion Trap System

Supporting Information

LC-MS/MS quantitative analysis of Polyunsaturated Omega 3, 6,7 and 9 Fatty Acids in Serum for

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

LCMS-8030 Application Report. Steroids: Testosterone, Progesterone, Estradiol, Ethinylestradiol

Determination of Chlorophenoxyacetic Acid and Other Acidic Herbicides Using a QuEChERS Sample Preparation Approach and LC-MS/MS Analysis

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Shotgun Proteomics MS/MS. Protein Mixture. proteolysis. Peptide Mixture. Time. Abundance. Abundance. m/z. Abundance. m/z 2. Abundance.

SUPPORTING INFORMATION FOR: CONCENTRATIONS OF POLYBROMINATED DIPHENYL ETHERS, HEXABROMOCYCLODODECANES AND TETRABROMOBISPHENOL-A IN BREAST MILK FROM

Neosolaniol. [Methods listed in the Feed Analysis Standards]

1.E+07 1.E+07 1.E+07 8.E+06 6.E+06 4.E+06 2.E+06

Author. Introduction. Abstract

Determination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Determination of Amantadine Residues in Chicken by LCMS-8040

Supporting information

Determination of Benzodiazepines in Urine by CE-MS/MS

Pål I. Holm, Per Magne Ueland, * Gry Kvalheim, and Ernst A. Lien. Clinical Chemistry 49: (2003) Nutrition

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Analysis of Vitamins Using an SFC/UHPLC Hybrid System with a Triple Quadrupole LC/MS for Quantification


Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

LC/MS Method for Comprehensive Analysis of Plasma Lipids

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

Isomer Separation of Positively Labeled N-glycans by CE-ESI-MS

Quantitation of Protein Phosphorylation Using Multiple Reaction Monitoring

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Identification and Quantitation of Microcystins by Targeted Full-Scan LC-MS/MS

SEPARATION OF BRANCHED PFOS ISOMERS BY UPLC WITH MS/MS DETECTION

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Author. Introduction. Small Molecule Pharmaceuticals & Generics

Phospholipid characterization by a TQ-MS data based identification scheme

Sulfate Radical-Mediated Degradation of Sulfadiazine by CuFeO 2 Rhombohedral Crystal-Catalyzed Peroxymonosulfate: Synergistic Effects and Mechanisms

Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography

Identification of Steroids in Water by Ion Trap LC/MS/MS Application

John Haselden 1, Gordon Dear 1, Jennifer H. Granger 2, and Robert S. Plumb 2. 1GlaxoSmithKline, Ware, UK; 2 Waters Corporation, Milford, MA, USA

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

INTRODUCTION CH 3 CH CH 3 3. C 37 H 48 N 6 O 5 S 2, molecular weight Figure 1. The Xevo QTof MS System.

Pilot experiments to investigate the glucuronidation of axitinib with human liver microsomes.

Comparison of Full Scan MS2 and MS3 Linear Ion Trap Approaches for Quantitation of Vitamin D

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Targeted and untargeted metabolic profiling by incorporating scanning FAIMS into LC-MS. Kayleigh Arthur

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

LC-MS/MS analysis of Chlorates in Milk and Whey Powder using the Agilent 6470 QQQ

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Supporting Information

Considerations of the use of Triple Quadrupoles or Ion Traps in Quantitative Applications

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Ozonolysis of phospholipid double bonds during electrospray. ionization: a new tool for structure determination

Dry eye disease commonly known as atopic keratoconjunctivitis is an autoimmune disease of

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Suppl. Table 1: CV of pooled lipoprotein fractions analysed by ESI-MS/MS

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

Vitamin D3 and related compounds by ESI and APCI

Quantitative Analysis of Amphetamine-Type Drugs by Extractive Benzoylation and LC/MS/MS. Application. Introduction. Authors. Abstract.

[ APPLICATION NOTE ] High Sensitivity Intact Monoclonal Antibody (mab) HRMS Quantification APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

The setup and validation of an LC-MS/MS assay of Androstenedione & Testosterone a labs experience

SUPPLEMENTARY MATERIAL

Application Note. Abstract. Authors. Pharmaceutical

Analysis of Limonin in Citrus Juice Using QuEChERS and LC-MS/MS

Paul D. Rainville Ph.D. Health Sciences Group Waters Corporation Waters Corporation 1

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

More structural information with MS n

Jose Castro-Perez, Henry Shion, Kate Yu, John Shockcor, Emma Marsden-Edwards, Jeff Goshawk Waters Corporation, Milford, MA, U.S. and Manchester, UK

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Summary Chapter 8 CHAPTER 8. Summary. Page 173

Edgar Naegele. Abstract

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

GC-MS/MS Analysis of Benzodiazepines Using Analyte Protectants

Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Fleet Ion Trap Mass Spectrometer and the Mass Frontier Software Package

Screening and quantitation of drugs in oral fluids using Q Exactive system

Analysis of Pesticides (II) Metribuzin & their metabolites in Rice Jun Yonekubo, Nihon Waters, JAPAN

Transcription:

Analysis of Choline and its Metabolites on the Finnigan LTQ Gargi Choudhary Diane Cho Thermo Electron, San Jose, CA Abstracted from a poster presented at Montreux 3 LC/MS Symposium, with co-authors: Brad Hart, Marie Caudill 1 1 Human Nutrition and Food Sciences Dept of Cal Poly Pomona

Goal: What we set out to demonstrate The applicability of the Finnigan LTQ to a quantitative method previously established on the LCQ Advantage The sensitivity and dynamic range of choline and its metabolites on the Finnigan LTQ The precision and quantitative characterization of the LTQ The limits of detection (LD) and quantitation (LQ) for this method on the LTQ 2

Background: What s the interest in cholines and its metabolites? Choline Part of several major phospholipids that are critical for normal cell membrane structure and lipoprotein function (1). A precursor of betaine, which is used by kidney to maintain water balance (2), and by liver as a source of methyl groups for methionine formation (3). Also used to produce acetylcholine, an important neurotransmitter (4). If deprived of choline, cells die of apoptosis (5-7)and humans develop liver dysfunctions (8). While the essentiality of cholines in several animals has long been recognized, a dietary recommendation for humans was only recently recommended by the US National Academy of Sciences (9). 3

Choline Compounds Analyte Structure MH+ Normalized Collision energy Product ions Betaine H N 118 58 and 59 Choline H N 14 Acetylcholine 146 32 87 N Generated with Mass Frontier software 4

Choline Compounds (2) Analyte Structure MH+ Normalized Collision energy Product ions Phosphochloline H P H N 184 32 86 Glycerophospho choline H H P H N 258 27 14 CDP choline H 2 N N N H H P H P N 489 27 1 Generated with Mass Frontier software 5

LC Conditions Surveyor MS Pump and Surveyor Autosampler Mobile Phase A: Acetonitrile/water/ethanol/1M ammonium acetate/glacial acetic acid (/127/68/3/2 v/v) B: Acetonitrile/water/ethanol/1M ammonium acetate/glacial acetic acid (//85/27/18 v/v) Column x 2.1 mm id packed with 5 µm Silica particles Injection volume: 1 µl Gradient: At % B for.5 min and µl/min; to % B in 5. min at µl/min; to % B in 2 min at 3 µl/min at % B for 3 min at µl/min to % A in 1 min at µl/min at % A for 6 min at µl/min 6

Conditions Electrospray, positive ionization Capillary temperature 31 C Spray voltage 4.5 kv Sheath gas Aux gas 1 7

LC/MS/MS Analysis of 3 Cholines RT:. - 6. SM: 7G 2.57 Acetylcholine Base Peak m/z= 86.-87. F: ITMS + c ESI Full ms2 146.@32. [.-1.] MS Genesis new_sample_16 2.34 2. Betaine Choline. 1. 2. 3. 4. 5. 6. Time (min) Base Peak m/z=57.-58.+58.- 59. F: ITMS + c ESI Full ms2 118.1@. [.-122.] MS Genesis new_sample_16 Base Peak m/z= 59.-. F: ITMS + c ESI Full ms2 14.1@42. [.-18.] MS new_sample_16 87.2 59.1.8 Relative Abundance.12 128.9146.9 7 9 11 13 1 58.6 86.1.7 11.5 1 75.11 86.7 55 65 75 85 95 15 8

LC/MS/MS of 3 Cholines RT:. - 4. SM: 7G Phosphocholine 2.47 Base Peak m/z= 85.-86. F: ITMS + c ESI Full ms2 184.@32. [.- 187.] MS new_sample_14 Glycerophosphocholine 2.48 Base Peak m/z= 13.-14. F: ITMS + c ESI Full ms2 258.@27. [ 7.- 261.] MS new_sample_14 Relative Abundance CDP choline 1.97 Base Peak m/z=.-1.+417.- 418. F: ITMS + c ESI Full ms2 489.@27.[ 1.-493.] MS new_sample_14 1. 2. 3. 4. Time (min).9 86.12 14.5 418.26 489.46 196.94.9 112.6 124.21 9 1 2 3 4 m/z 1 1 1 1 1 m/z m/z

Calibration Curve for Acetylcholine 44 Y =.41943*X R^2 =.9996 W: Equal Area Ratio 36 32 28 24 16 12 8 4 Acetylcholine N Dynamic Range fmol 1 nmol (> five orders of magnitude) 3 7 9 Amount (pgs on-column) 1

Same-Day Assay Precision for Acetylcholine Amount on column % CV fmol 11.6 fmol 1 pmol 1 pmol pmol 1 nmol 1 nmol 7.56 5.2 1.32 1.85 2.3 1.82 * For three injections 11

Calibration Curve for Glycerophosphocholine 2.8 Y =.252578*X R^2 =.999 W: Equal Area Ratio 2.4 2. 1.6 1.2.8 H Glycerphosphocholine H P H N Dynamic Range fmol-1 nmol (five orders of magnitude).4. 3 7 9 Amount (pgs on-column) 12

Same-Day Assay Precision for Glycerophosphocholine Amount on column % CV fmol 3.95 fmol 5.63 5 pmol 2.14 pmol 3.88 pmol 3.9 1 nmol 2.74 5 nmol 1.24 1 nmol 1.12 * For three injections 13

LD for Acetylcholine and Glycerphosphocholine S/N: 9 Acetylcholine 25 fmol on-column Base Peak m/z= 86.-87. F: ITMS + c ESI Full ms2 146.@32. [.-149.] Relative Abundance S/N: 13 Glycerophosphocholine fmol on-column Base Peak m/z= 13.-14. F: ITMS + c ESI Full ms2 258.@27. [7.-261.] 1. 2. 3. 4. 5. Time (min) 6. 14

LD* and LQ* Analyte Acetylcholine Glycerophosphocholine LD (on-column) 25 fmol fmol LQ (on-column) fmol fmol * In water 15

Choline and Betaine from Pooled Liver Extract S:N Comparison Finnigan LTQ Finnigan LCQ Advantage RT: 4. - 12. X 5.5 RT: 4. - 12. 9 S/N: 263 Base Peak F: ITMS + c ESI Full ms2 14.1@. [.-18.] MS 9 S/N:47 Base Peak F: + c Full ms2 14.1@35. [.-11.] MS Relative Abundance 7 3 9 Relative Abundance 7 3 Choline 1 1 9 S/N: 71 X 1 Base Peak F: ITMS + c ESI Full ms2 118.1@38. [.-122.] MS 9 S/N: 7 Betaine Base Peak F: + c ESI Full ms2 118.1@38. [.-1.] MS 7 7 3 3 1 1 4 5 6 7 8 1 11 12 Time (min) 4 5 6 7 8 9 1 11 12 Time (min) 16

Choline and Betaine from Pooled Liver Extract # Scans Across the LC Peak Finnigan LTQ Finnigan LCQ Advantage Relative Abundance 9 7 3 1 RT: 4. - 12. 9.9 7.53.7 Base Peak F: ITMS 59.98 + c ESI Full ms2 14.1@. [ 9.-18.] MS AqStd_nmol_2 Relative Abundance 7 3 1 Choline Base Peak F: + c Full ms2 14.1@35. [.-11.] MS aqstd_nmol_2 9 7.34 58.99 Base Peak F: ITMS + c ESI Full ms2 118.1@38. [.-122.] MS AqStd_nmol_2 9 6.68 58.13 Betaine Base Peak F: + c ESI Full ms2 118.1@38. [.-1.] MS aqstd_nmol_2 7 7 99.92 9.6. 9.67 99.82 Quan on this?? 3 3 1 1 7 8 9 1 Time (min) 4 5 6 7 8 9 1 11 12 Time (min) 17

Conclusions Full scan MS/MS analysis with the Finnigan LTQ linear ion trap mass spectrometer provides the selectivity and sensitivity for the analysis of choline compounds Accurate quantitation of choline compounds with a linear dynamic range over five orders of magnitude is achieved on the Finnigan LTQ. The Finnigan LTQ provides excellent within-day assay precision for the analysis of choline compounds. The CV for glycerophosphocholine is less than 6% for the entire linear dynamic range. The CV for acetylcholine is less than 8% except near LQ where the CV is 11.6%. The limit of quantitation is determined from the calibration curves as fmol for acetylcholine and fmol for glycerophosphocholine. The LD for acetylcholine is determined to be 25 fmol (on-column) with a signal to noise ratio of 9:1, whereas that for glycerophosphocholine is determined to be fmol (on-column) with a signal to noise of 13:1 18

Acknowledgements Marie Caudill, Cal Poly Pomona University Brad Hart Jonathan McNally Jae Schwartz Lester Taylor Rohan Thakur 19

References 1. Zeisel, S.H. Nutrition, 16, 669-671. 2. Burg, M. Am. J. Physiol. 1995, 268, F983-F996 3. Dudman, N; Guo, X; Gordon E,; Dawson, P; Wilcken D. J. Nutr. 1996, 126,1295S-13S 4. Haubrich, D. R; Wang, P. F.; Herman, R. L.; Clody, D.E., Life Sci. 1975, 17, 739-747 5. Holmes-McNary, M. Q,; Loy, R.; Mar, M. H.; Albright, C. D.; Zeisel, S. H. Dev. Brain Res. 1997, 11, 9-16. 6. Yen, C. L.; Mar, M. H.; Zeisel, S. H. FASEB J. 1999, 13, 135-142 7. Albright, C. D.; Salganik, R. I.; Kaufmann, W.K.; Vrablic, A. S.; Zeisel, S. H. J. Nutr. Biochem. 1998, 9, 476-481

References 8. Zeisel, S. H.; DaCosta, K. A.; Franklin, P.D.; Alexander, E. A.; Lamont, J. T.; Sheard, N. F.; Beiser, A. FASEB J. 1991, 5, 93-98 9. Institute of Medicine: National Academy of Sciences U.S.A. Dietry reference intakes of folate thiamin riboflavin, niacin, vitamin B12, panthothenic acid, biotin, and choline; National Academy press: Washington, DC 1998 1. Koc, H.; Mar, M. H.; Ranasinghe, A.; Swenberg, J. A.; Zeisel, S. H.; Anal. Chem. 2, 74, 4734-47. 21